Charles J. Betlach
Keine laufenden Positionen mehr
Profil
Charles J.
Betlach was the founder of Sano Corp.
(founded in 1991), where he held the title of Executive Vice President-Research & Development in 1998.
He also held former positions as Director at Concordia Pharmaceuticals, Inc., Principal Scientist at Schering-Plough Corp.
(1984-1991), Vice President-New Product Development at Brickell Subsidiary, Inc., and Principal Scientist at Key Pharmaceuticals, Inc. Dr. Betlach received a graduate degree from the University of California, Santa Barbara in 1967, and two doctorate degrees from the University of California, San Francisco in 1974 and 1978.
Ehemalige bekannte Positionen von Charles J. Betlach
| Unternehmen | Position | Ende |
|---|---|---|
Sano Corp.
 Sano Corp. Pharmaceuticals: MajorHealth Technology Sano Corp. produces plastic membranes. The company is based in Miramar, FL. The company was founded in 1991 by Reginald L. Hardy, Charles J. Betlach. Sano was acquired by Elan Corp. Plc on March 02, 1998 for $391.16 million. | Gründer | 01.01.1998 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | 01.01.1991 |
Key Pharmaceuticals, Inc.
 Key Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Key Pharmaceuticals, Inc. operates as a subsidiary of Schering-Plough which is engaged in manufacturing, fabricating or processing drugs in pharmaceutical preparations. The company is located in Newark, NJ | Technik-/Wissenschafts-/F&E-Leiter | - |
Brickell Subsidiary, Inc.
 Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Corporate Officer/Principal | - |
Concordia Pharmaceuticals, Inc.
 Concordia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concordia Pharmaceuticals Inc. operated as a pharmaceutical development management company. It focuses on the acquisition, in-licensing and development of cancer therapies. The company was founded by Marc Watson and Hubert E. Huckel in 2003 and headquartered in Miami, FL. | Direktor/Vorstandsmitglied | - |
Ausbildung von Charles J. Betlach
| University of California, Santa Barbara | Graduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Concordia Pharmaceuticals, Inc.
Concordia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concordia Pharmaceuticals Inc. operated as a pharmaceutical development management company. It focuses on the acquisition, in-licensing and development of cancer therapies. The company was founded by Marc Watson and Hubert E. Huckel in 2003 and headquartered in Miami, FL. | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Health Technology |
Sano Corp.
Sano Corp. Pharmaceuticals: MajorHealth Technology Sano Corp. produces plastic membranes. The company is based in Miramar, FL. The company was founded in 1991 by Reginald L. Hardy, Charles J. Betlach. Sano was acquired by Elan Corp. Plc on March 02, 1998 for $391.16 million. | Health Technology |
Key Pharmaceuticals, Inc.
Key Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Key Pharmaceuticals, Inc. operates as a subsidiary of Schering-Plough which is engaged in manufacturing, fabricating or processing drugs in pharmaceutical preparations. The company is located in Newark, NJ | Health Technology |
